SynthesisThe Cochrane database of systematic reviews2023

Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).

Matthew Heneghan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.